Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Multicentre Clinical Study of the Hemoteq Ranger™ Paclitaxel-Coated PTA Balloon Catheter (Ranger DCB) in Comparison to Uncoated PTA Balloons in Femoropopliteal Lesions

NCT02013193 is registered in ClinicalTrials.gov with Hemoteq AG as lead sponsor.

NCT NCT02013193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02013193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Multicentre Clinical Study of the Hemoteq Ranger™ Paclitaxel-Coated PTA Balloon Catheter (Ranger DCB) in Comparison to Uncoated PTA Balloons in Femoropopliteal Lesions
Lead sponsor
Hemoteq AG
Phase
Not applicable
Overall status
Completed
Start date
January 7, 2014
Completion date
March 15, 2019
Enrollment
105 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, atherosclerosis, claudication, peripheral artery disease